➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Patent: 4,959,314

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 4,959,314
Title: Cysteine-depleted muteins of biologically active proteins
Abstract:Muteins of biologically active proteins such as IFN-.beta. and IL-2 in which cysteine residues that are not essential to biological activity have been deleted or replaced with other amino acids to eliminate sites for intermolecular crosslinking or incorrect intramolecular disulfide bridge formation. These muteins are made via bacterial expression of mutant genes that encode the muteins that have been synthesized from the genes for the parent proteins by oligonucleotide-directed mutagenesis.
Inventor(s): Mark; David F. (Danville, CA), Lin; Leo S. (Fremont, CA), Yu Lu; Shi-da (Oakland, CA), Wang; Alice M. (Walnut Creek, CA)
Assignee: Cetus Corporation (Emeryville, CA)
Application Number:06/698,939
Patent Claims:see list of patent claims

Details for Patent 4,959,314

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bayer Healthcare Pharms BETASERON interferon beta-1b VIAL; SUBCUTANEOUS 103471 001 1993-07-23 ⤷  Free Forever Trial Cetus Corporation (Emeryville, CA) 2002-10-19 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 4,959,314

Country Patent Number Estimated Expiration
South Africa 8507906 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 8602381 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 8604606 ⤷  Free Forever Trial
United States of America 4677063 ⤷  Free Forever Trial
United States of America 4677064 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.